MEDICALIP LOGO

MEDICAL IP, awarded by the Ministry of SMEs and Startup

[MEDICAL IP received a commendation from the Minister of SMEs and Startups]



▶ Recognized for leading industrial development and local community growth through the development of an AI medical platform incorporating advanced technology


▶ “We will solidify our position as Korea’s leading AI medical solution company by continuously strengthening corporate competitiveness”


MEDICAL IP received a commendation from the Minister of SMEs and Startups
MEDICAL IP received a commendation from the Minister of SMEs and Startups.

MEDICAL IP was recognized for its contribution to industrial development and innovative growth of the local community by developing a number of medical platforms incorporating advanced technologies such as AI, 3D printing, and XR based on the original technology that visualizes black and white 2D medical images in 3D color.

A company official said, “Based on the AI medical image analysis technology developed in-house, it has been steadily growing since its establishment by introducing a variety of technologies and products suitable for the 4th industry. At the same time, the award was given in recognition of the development of a COVID-19 response solution and non-face-to-face medical service platform.”

In response, CEO Park Sang-joon said, “I feel a great sense of responsibility and mission to receive a commendation for merit in recognition of my contribution to the development of the industry and the growth of the local community. We will solidify our position as a solution company.”

LATEST NEWS

Article
Oct 4 / 2024

MEDICAL IP unveils innovative AI solutions at K-hospital, marking visible achievements

Article
Sep 30 / 2024

MEDICAL IP Showcases New Medical Education Possibilities with AI & Metaverse at the ‘Medical Metaverse Conference’

Article
Sep 9 / 2024

MEDICAL IP unveils latest MEDIP Box lineup at the IFAA 2024, paving the way for the future of anatomy education

1/50

Questions on our public relations?

Ask us now.